November 1, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has committed distribution licenses for its Pot-O-Coffee brands in the states of Oregon, Washington, Illinois and Colorado.
The Company has entered an agreement with Nutritional High (EAT: CNX), to distribute the Company’s Pot-O-Coffee, Pot-O-Tea, and Pot-O-Coco product lines. The agreement will focus on specific markets in Colorado, Oregon, Washington and Illinois, in cooperation with Nutritional High’s partner companies. As a part of this agreement, Nutritional High will complete the final stage of manufacturing by infusing its cannabis into the product and will provide a royalty to Isodiol.
“This strategic alliance with Nutritional High will offer our customers greater access to Pot-O-Coffee products via a reputable manufacturer and distributor, said Marcos Agramont, CEO of Isodiol. With the recent transaction involving our Canadian licensing partner (see news release announced July 20, 2017) Canopy Growth Corporation and Constellation Brands, we feel the infused beverage industry will make significant strides in the near future.”
Jim Frazier, CEO of Nutritional High commented: “We are pleased to announce the joint commercialization strategy with Isodiol. We feel that an opportunity to work with a leading international player in the space that has a track record with developing and commercializing cannabis-based consumer products. This partnership will help us expand our product reach in North America and leverage the infrastructure that we have and continue to build.”
In addition to the licensing agreement, Isodiol is also pleased to announce the 100% acquisition of the assets of Culinary Coffee Roasters, LLC, a leading roaster and purveyor of fine coffee, tea and blended formulations, based in Stuart, Florida. Culinary has been in the coffee beverage business for over fifteen years. With the acquisition of this facility, the Company will be poised to launch specialty blends that will be roasted in their own facility and will be availed to mainstream retail outlets that are currently being served by Culinary. In consideration for the acquisition, Isodiol will pay $50,000 in cash over three months and $450,000 in stock equity, subject to a maximum escrow period.
This move highlights Isodiol’s focus on investing in high-growth markets and acting on consumer trends,” said Agramont. “Culinary Coffee is one of the South Florida’s fastest growing specialty coffee roasters and has been in the business for more than 15 years. With their industry expertise and passion for quality coffee, we will be able to further position ourselves in the recreational beverage market.”
Further, Isodiol is launching its own line of handcrafted Ready to Drink (RTD) beverages in the 1st Quarter 2018. These products will include an RTD cold brew Pot-O-Coffee line as well as a cold brew Pot-O-Coffee line, all enriched with BioActive Phytoceuticals. Other offerings will include infused coffee and tea shots.
About Isodiol International Inc.
Isodiol International Inc. is the market leader in pharmaceutical and nutraceutical grade phytochemical compounds and the industry leader in the manufacturing and development of phytoceutical consumer products.
Isodiol is the pioneer of many firsts for the cannabis industry including commercialization of 99%+ pure, bioactive pharmaceutical grade cannabinoids, micro-encapsulations, and nanotechnology for the highest quality consumable and topical skin care products.
Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its phytoceutical portfolio and will aggressively continue international expansion into Latin America, Asia and Europe.
ON BEHALF OF THE BOARD
“Marcos Agramont” CEO & Director
COMPANY MEDIA :
North 6th Agency
Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business, products and future the Company’s business, its product offerings and plans for sales and marketing. Although the Company believes that the expectations reflected in the forward looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned to not place undue reliance on forward-looking information. Such forward looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company’s products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation, and does not intend, to update any forward looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.
The CSE has not reviewed, approved or disapproved the content of this press release.